Earnings Presentation Materials for the Fiscal Year Ending March 2026 | Wellness Communications Corporation (366A) timely disclosure

Worth reading

48Recurring

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Improvement

Direction inferred from the company’s description.

Scale

5.1

% (year-on-year change in revenue)

Wording

Conditional

How definitive the wording is.

Contents of this document

Financial results presentationFiscal year ending March 2026, full year9 items taken from the company’s own explanation

Financial Results Figures (The key points of this material are explained below)

Net Sales¥14,778 million+5.1%

Operating profit¥1,186 million+6.9%

Net income¥822 million+5.9%

Gross Profit Margin21.0％

Operating profit margin8.0％

Full-year earnings forecast

Fiscal year ending March 2027

Net Sales

¥17,500 million

Gross profit

¥4,800 million

Operating profit

¥1,600 million

Net income attributable to owners of the parent

¥1,150 million

EBITDA

¥2,100 million

What the company explained in this material

Self-assessment against the planThe company's self-assessment against its own plan.

Adjusted operating profit and net profit, excluding one-time M&A-related expenses, met the initial plan

Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.

Business Expansion+¥173 million
Cost savings through BPR/DX initiatives and the use of AI+¥34 million
R&D investment in generative AI and other initiatives, including functional enhancements−¥10 million
Due diligence and financial advisory fees for M&A transactions-¥55 million
Investment in Human Resources-¥47 million
Goodwill amortization-¥16 million
Due diligence and financial advisory fees for M&A transactions (added back to adjusted operating profit)+¥55 million

New initiatives

Investment to develop Growbase as a platform
Growbase pricing revision
Development and planned launch of Omakase Health Management for mid-sized and small companies
Development of an end-to-end cancer screening support service
Enhancement of the health checkup results digitization process through the use of AI
PMI for Ashita no Team
Introduction of a business-owner system
Relocation of the Osaka office and opening of the Wellness Intelligence Lab. on 1 June 2026

Key KPIsA metric the company considers important as a management benchmark.

Number of corporate groups with Growbase contracts262 Group
Year on year against the same period last year+30 groups
Users of network health checkup services39.8 10,000 people
Year on year against the same period last year+0.94万人
NRR (net revenue retention rate for recurring revenue)107 ％
Operating profit per employee¥7 million
Year on year against the same period last year＋22.4％
Company-wide adjusted operating profit per employee¥9.7 million
Year on year against the same period last year＋5.9％

Unit price and quantity metricsThese figures show sales broken down by price and volume.

Number of corporate groups under contract1,843 Corporate groups
Year on year against the same period last year+1,363 corporate groups
Number of contracted companies4,943 companies
Year on year against the same period last year+1,403 companies
Number of IDs250 10,000 IDs
Year on year against the same period last year+25.0万ID
NRR (net revenue retention rate for recurring revenue)107 ％

Segment results

Health Management Cloud Business

Net Sales

¥1,523 million+23.7%

Gross profit

¥1,269 million+24.7%

Operating profit

¥767 million+6.3%

Health Checkup Solutions Business

Net Sales

¥13,018 million+3.8%

Gross profit

¥1,798 million+7.3%

Operating profit

¥379 million+29.6%

Number of employees

Consolidated263 people

Standalone128 people

Record date31 March 2026

Annual Dividend

Fiscal year ending March 2026

Dividend per share¥34.4

Forecast for the fiscal year ending March 2027

Dividend per share¥40

Payout ratio

Not disclosed (progressive dividend policy introduced in February 2026)

Contents of this document
Item	Details
Document type	Financial results presentation
Fiscal Period Covered	Fiscal year ending March 2026, full year
Net Sales	¥14,778 million (YoY +5.1%)
Operating profit	¥1,186 million (YoY +6.9%)
Net income	¥822 million (YoY +5.9%)
Gross Profit Margin	21.0％
Operating profit margin	8.0％
Full-year earnings forecast	Fiscal year ending March 2027 Net Sales ¥17,500 million / Gross profit ¥4,800 million / Operating profit ¥1,600 million / Net income attributable to owners of the parent ¥1,150 million / EBITDA ¥2,100 million
Self-assessment against the plan	Adjusted operating profit and net profit, excluding one-time M&A-related expenses, met the initial plan
Segment results	Health Management Cloud Business Net Sales ¥1,523 million (YoY +23.7%) / Gross profit ¥1,269 million (YoY +24.7%) / Operating profit ¥767 million (YoY +6.3%) / Health Checkup Solutions Business Net Sales ¥13,018 million (YoY +3.8%) / Gross profit ¥1,798 million (YoY +7.3%) / Operating profit ¥379 million (YoY +29.6%)
Breakdown of Factors Affecting the Change	Factors Business Expansion / Amount +¥173 million, Factors Cost savings through BPR/DX initiatives and the use of AI / Amount +¥34 million, Factors R&D investment in generative AI and other initiatives, including functional enhancements / Amount −¥10 million, Factors Due diligence and financial advisory fees for M&A transactions / Amount -¥55 million, Factors Investment in Human Resources / Amount -¥47 million, Factors Goodwill amortization / Amount -¥16 million, Factors Due diligence and financial advisory fees for M&A transactions (added back to adjusted operating profit) / Amount +¥55 million
Key KPIs	Indicator name Number of corporate groups with Growbase contracts / Value 262 Group / Year on year against the same period last year +30 groups, Indicator name Users of network health checkup services / Value 39.8 10,000 people / Year on year against the same period last year +0.94万人, Indicator name NRR (net revenue retention rate for recurring revenue) / Value 107 ％ / Year on year against the same period last year Not disclosed, Indicator name Operating profit per employee / Value ¥7 million / Year on year against the same period last year ＋22.4％, Indicator name Company-wide adjusted operating profit per employee / Value ¥9.7 million / Year on year against the same period last year ＋5.9％
Unit price and quantity metrics	Indicator name Number of corporate groups under contract / Value 1,843 Corporate groups / Year on year against the same period last year +1,363 corporate groups, Indicator name Number of contracted companies / Value 4,943 companies / Year on year against the same period last year +1,403 companies, Indicator name Number of IDs / Value 250 10,000 IDs / Year on year against the same period last year +25.0万ID, Indicator name NRR (net revenue retention rate for recurring revenue) / Value 107 ％ / Year on year against the same period last year Not disclosed
Number of employees	Consolidated 263 people / Standalone 128 people / Record date 31 March 2026
Annual Dividend	Fiscal year ending March 2026 Dividend per share ¥34.4 / Forecast for the fiscal year ending March 2027 Dividend per share ¥40 / Interim and Year-End Breakdown Not disclosed
Payout ratio	Not disclosed (progressive dividend policy introduced in February 2026)
New initiatives	Investment to develop Growbase as a platform, Growbase pricing revision, Development and planned launch of Omakase Health Management for mid-sized and small companies, Development of an end-to-end cancer screening support service, Enhancement of the health checkup results digitization process through the use of AI, PMI for Ashita no Team, Introduction of a business-owner system, Relocation of the Osaka office and opening of the Wellness Intelligence Lab. on 1 June 2026

Items this document does not state (14)

Ordinary incomeSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company cited growth in its core businesses, an increase in the number of corporate groups using Growbase through direct sales and new-business development, an expansion in users of its network health checkup services, and reductions in outsourcing and other costs through BPR/DX initiatives and the use of AI. At the same time, it carried out growth investments, including the development of Growbase as a platform, the use of AI, talent recruitment and M&A.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.